Page last updated: 2024-12-07

thiamine thiazolone pyrophosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

thiamine thiazolone pyrophosphate: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID124687
CHEMBL ID403021
MeSH IDM0062581

Synonyms (16)

Synonym
2-{3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-2-oxo-2,3-dihydro-1,3-thiazol-5-yl}ethyl trihydrogen diphosphate
thiamin thiazolone diphosphate
1RP7 ,
CHEMBL403021 ,
59733-97-0
2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-2-oxo-1,3-thiazol-5-yl]ethyl phosphono hydrogen phosphate
thiamine thiazolone pyrophosphate
bdbm50373878
diphosphoric acid, mono(2-(3-((4-amino-2-methyl-5-pyrimidinyl)methyl)-2,3-dihydro-4-methyl-2-oxo-5-thiazolyl)ethyl) ester
thiamine thiazolone diphosphate
8fl ,
2-{3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-2-oxo-2,3-dihydro-1,3-thiazol-5-yl}ethyl trihydrogen
Q27466792
DTXSID20975145
2-{3-[(6-imino-2-methyl-1,6-dihydropyrimidin-5-yl)methyl]-4-methyl-2-oxo-2,3-dihydro-1,3-thiazol-5-yl}ethyl trihydrogen diphosphate
2-(3-((4-amino-2-methylpyrimidin-5-yl)methyl)-4-methyl-2-oxo-2,3-dihydrothiazol-5-yl)ethyl trihydrogen diphosphate

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Pyruvate dehydrogenase E1 componentsynthetic constructKi0.00300.00300.00300.0030AID977610
Chain B, Pyruvate dehydrogenase E1 componentsynthetic constructKi0.00300.00300.00300.0030AID977610
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
TransketolaseHomo sapiens (human)Kd0.01600.01600.01600.0160AID320588
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (5)

Processvia Protein(s)Taxonomy
pentose-phosphate shuntTransketolaseHomo sapiens (human)
pentose-phosphate shunt, non-oxidative branchTransketolaseHomo sapiens (human)
regulation of growthTransketolaseHomo sapiens (human)
glyceraldehyde-3-phosphate biosynthetic processTransketolaseHomo sapiens (human)
xylulose 5-phosphate biosynthetic processTransketolaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (6)

Processvia Protein(s)Taxonomy
magnesium ion bindingTransketolaseHomo sapiens (human)
transketolase activityTransketolaseHomo sapiens (human)
calcium ion bindingTransketolaseHomo sapiens (human)
protein bindingTransketolaseHomo sapiens (human)
protein homodimerization activityTransketolaseHomo sapiens (human)
thiamine pyrophosphate bindingTransketolaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (7)

Processvia Protein(s)Taxonomy
nucleoplasmTransketolaseHomo sapiens (human)
peroxisomeTransketolaseHomo sapiens (human)
cytosolTransketolaseHomo sapiens (human)
nuclear bodyTransketolaseHomo sapiens (human)
vesicleTransketolaseHomo sapiens (human)
extracellular exosomeTransketolaseHomo sapiens (human)
endoplasmic reticulum membraneTransketolaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2004Biochemistry, Mar-09, Volume: 43, Issue:9
Structural determinants of enzyme binding affinity: the E1 component of pyruvate dehydrogenase from Escherichia coli in complex with the inhibitor thiamin thiazolone diphosphate.
AID1811Experimentally measured binding affinity data derived from PDB2004Biochemistry, Mar-09, Volume: 43, Issue:9
Structural determinants of enzyme binding affinity: the E1 component of pyruvate dehydrogenase from Escherichia coli in complex with the inhibitor thiamin thiazolone diphosphate.
AID320588Inhibition of apo-transketolase2008Bioorganic & medicinal chemistry letters, Jan-15, Volume: 18, Issue:2
Non-charged thiamine analogs as inhibitors of enzyme transketolase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (50.00)18.7374
1990's2 (20.00)18.2507
2000's3 (30.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.80

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.80 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.20 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.80)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]